ArticlePhysics and imaging in radiation oncology2025
Quantifying movement of optical structures during radiotherapy treatment for tumors near the orbita.
Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimodal deep learning to support delineation of neuro-oncology organs based on the EPTN international neurological contouring atlas.Physics and imaging in radiation oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Movement of optical structures during radiotherapy for tumors near the orbita might affect the amount of radiation given and consequently the risk for side effects. The aim of this study was therefore to quantify motion of optical structures during radiotherapy. Materials and methods: Twenty brain tumor patients were retrospectively included, with planning computed tomography (CT)-scan (pCT) and five repeat-CT-scans (reCTs) without gazing instructions. Six optical structures were delineated bilaterally: lens, cornea, retina, lacrimal glands, macula, and optic nerves (ON). The ON was split in three subregions. The dice similarity coefficient (DSC), absolute distance (AD), and difference in 3D midpoint (ΔMP) were calculated between pCT and reCT. Planning risk volume (PRV)-margins and isotropic expansions to cover 95 % volume for 90 % patients were calculated. A dose-volume proof-of-principle was performed for a neurological and nasopharyngeal tumor. Results: Highest median ΔMP was found for the cornea: 1.9 mm. For ON subregions, highest median and 95th-percentile ΔMP was found for proximal intra-orbital ON: 1.3 mm and 3.1 mm. ON showed highest median AD: 3.0 mm (negative Z-direction). Open eyelid status resulted in statistically significant lower DSC for ON, intra-cranial ON, and proximal intra-orbital ON, and higher ΔMP for proximal intra-orbital ON. 1-4 mm isotropic expansions were needed for separate structures, dependent on typical movement range. Higher dose-differences were found for the neurological than the nasopharyngeal plan. Conclusions: The observed movement of optical structures indicated that a PRV-margin should be considered in clinical practice. Asking the patient to close their eyes during the treatment could decrease the movement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.